Cetera Trust Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Buy |
2,430
+240
| +11% | +$30.2K | 0.18% | 104 |
|
|
2025
Q1 | $242K | Hold |
2,190
| – | – | 0.15% | 138 |
|
|
2024
Q4 | $299K | Hold |
2,190
| – | – | 0.19% | 91 |
|
|
2024
Q3 | $252K | Hold |
2,190
| – | – | 0.15% | 133 |
|
|
2024
Q2 | $301K | Hold |
2,190
| – | – | 0.19% | 93 |
|
|
2024
Q1 | $302K | Sell |
2,190
-125
| -5% | -$17.2K | 0.18% | 98 |
|
|
2023
Q4 | $305K | Buy |
+2,315
| New | +$305K | 0.19% | 91 |
|